What are the possible causes of elevated ferritin associated with vertigo?

Differential Diagnosis of Raised Ferritin with Vertigo

When evaluating a patient with elevated ferritin and vertigo, consider iron deficiency (paradoxically), benign paroxysmal positional vertigo (BPPV), hemochromatosis, inflammatory conditions, malignancy, and infection as the primary differential diagnoses.

Algorithmic Approach to Diagnosis

Step 1: Determine the Degree of Ferritin Elevation

• Mild elevation (100-1000 μg/L): Consider iron deficiency with inflammation, BPPV with metabolic factors, or early hemochromatosis
• Marked elevation (>1000 μg/L): Prioritize malignancy (most common at 24%), iron overload syndromes (22%), infection (21%), and hepatocellular disease (12%) 1
• Extreme elevation (>4000 μg/L): Consider malignancy (35%), iron overload (35%), infectious disease (21%), hepatocellular disease (12%), autoimmune disease, or hemophagocytic lymphohistiocytosis (HLH) 2

Step 2: Assess for Iron Deficiency Despite Elevated Ferritin

Critical pitfall: Ferritin is an acute-phase reactant that becomes elevated with inflammation, masking underlying iron deficiency 3. This paradoxical situation directly links to vertigo symptoms.

• Measure transferrin saturation (TSAT) alongside ferritin
• Iron deficiency is present if TSAT <20%, even with ferritin 100-300 μg/L 3
• Vertigo/dizziness is significantly more common in iron-deficient patients 4, and iron supplementation significantly reduces these symptoms 4
• Recent data shows low serum ferritin, vitamin D, calcium, and uric acid are risk predictors for BPPV 5

Step 3: Evaluate for BPPV

BPPV is the most common peripheral vestibular disorder and has specific metabolic associations:

• Perform Dix-Hallpike maneuver and supine roll test 6
• Look for characteristic nystagmus: torsional with upbeating on Dix-Hallpike for posterior canal BPPV (71% of cases) 5
• Red flags suggesting central (non-BPPV) vertigo 6:
  • Downbeating nystagmus without torsional component
  • Direction-changing nystagmus without head position changes
  • Baseline nystagmus without provocative maneuvers
  • Associated dysarthria, dysmetria, dysphagia, or sensory/motor deficits

BPPV-specific metabolic risk factors include vitamin D deficiency, low calcium, low magnesium, hypertension, diabetes, poor sleep quality, and low ferritin 5. These patients require both canalith repositioning and metabolic correction.

Step 4: Assess for Hemochromatosis

If ferritin is elevated with transferrin saturation >45%:

• Order HFE genotyping for p.C282Y mutation 7
• Perform MRI with R2 sequences* to quantify hepatic iron concentration 7
• Assess for extrahepatic organ involvement (pancreas, heart, brain) 7
• Note: Hemochromatosis itself does not typically cause vertigo, but associated organ damage might

Step 5: Rule Out Serious Causes in Extreme Hyperferritinemia

For ferritin >4000 μg/L, systematically evaluate:

• Malignancy screening: Most common cause at this level 2
• Infection workup: Including uncommon infections (HIV, dengue, syphilis, murine typhus) 2
• HLH criteria: Median ferritin 19,138 μg/L in HLH; 80% mortality if cause unexplained 2
• Autoimmune conditions: Median ferritin 10,616 μg/L 2

Step 6: Consider Vestibular Migraine

Distinguish from BPPV by:

• Episodes lasting 5 minutes to 72 hours (not seconds like BPPV)
• History of migraine headaches
• Photophobia, phonophobia, or visual aura during ≥50% of dizzy episodes 6

Management Implications

For iron deficiency with elevated ferritin (inflammatory state):

• Supplement with 60 mg elemental iron daily for optimal correction 8
• Recheck ferritin and TSAT at 56 days
• Expect significant reduction in vertigo/dizziness symptoms 4

For BPPV with metabolic abnormalities:

• Perform canalith repositioning procedure
• Supplement vitamin D, calcium, and iron as indicated 5
• Address modifying factors: assess fall risk, mobility impairment, CNS disorders 6

For hemochromatosis with iron overload:

• Initiate phlebotomy therapy 7
• Monitor with MRI for tissue iron quantification 7

Critical Caveats

• Assay variability: Ferritin measurements differ by manufacturer; Roche assays read approximately 1.6× higher than Beckman assays 9. A Beckman value of 50 μg/L equals approximately 83 μg/L on Roche 9.
• Unexplained extreme hyperferritinemia carries 80% mortality 2; aggressive workup is mandatory
• 12-fold increased fall risk in older adults with dizziness 6; assess fall risk in all BPPV patients
• In inflammatory conditions, standard ferritin threshold <30 μg/L does not apply; use <100 μg/L or TSAT <20% instead 3